Giving in Europe & the Middle East
Gilead Sciences funds nonprofit-led projects in Europe and the Middle East to advance scientific knowledge, awareness, and care in HIV, liver disease, hematology, oncology, and inflammatory/respiratory diseases.
Funder: Gilead Sciences
Due Dates: Rolling (applications accepted year-round; must apply at least six weeks before project start)
Funding Amounts: No fixed maximum; applicants should request the amount needed for the project. Typical review period is 6–12 weeks.
Summary: Supports nonprofit-led projects in Europe and the Middle East to advance care, awareness, and access in HIV, liver disease, hematology, oncology, and inflammatory/respiratory diseases.
Key Information: Only nonprofits are eligible; grants do not cover clinical studies, patient care, or general operating expenses.
Description
Gilead Sciences offers grant funding to nonprofit organizations, patient advocacy groups, healthcare institutions, and professional associations in Europe and the Middle East. The program aims to support projects that advance disease awareness, prevention, professional education, and initiatives to improve access to and quality of care in the core therapeutic areas of HIV, liver diseases, hematology and oncology, and inflammatory and respiratory diseases. The grants are designed to foster meaningful collaborations and community engagement, enhancing healthcare outcomes in the region.
